Delivery Order SPE2DB20D2014-SPE2DB25FC89H
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $9.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,883.59 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered from...
- The Defense Logistics Agency awarded a $3,043.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of HUMIRA(CF) Pen 40 mg/0.4 mls, a biological immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract has no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,356.75 on September 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic medication used to treat inflammatory conditions. This firm fixed-price delivery order, which represents no set-aside designation, is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,542.07 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. HUMIRA is a leading biologic immunosuppressant medication used to treat various...
- The Defense Logistics Agency awarded a delivery order valued at $12,823.53 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. HUMIRA is a widely used...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used primarily for treating rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order has a ceiling value of $2,598.96 and an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating it was awarded through open competition. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a specialty pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, valued at $11,500.66, is scheduled for completion by August 14, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $5,330.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable medication used to treat autoimmune conditions. The contract, with an ultimate completion date of September 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was made on a competitive basis with no...
- The Defense Logistics Agency awarded a delivery order valued at $9,166.56 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competed delivery order under AmerisourceBergen's existing DLA contract vehicle. The place of performance is listed as the company's corporate office in...
- The Defense Logistics Agency has awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL units. This competitively awarded, firm fixed price contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a widely used biologic medication for treating autoimmune conditions including rheumatoid arthritis,...